# In Vivo Evaluation of the Physiological Effects of Arabinoxylan-oligosaccharides (AXOS) in Healthy Subjects (Juniors)

> **NCT01001949** · NA · COMPLETED · sponsor: **Fugeia NV** · enrollment: 29 (actual)

## Conditions studied

- Gastrointestinal Health
- Healthy Subjects

## Interventions

- **DIETARY_SUPPLEMENT:** Wheat Bran Extract
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT01001949
- **Lead sponsor:** Fugeia NV
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-05
- **Final completion:** 2009-10
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2009-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001949, "In Vivo Evaluation of the Physiological Effects of Arabinoxylan-oligosaccharides (AXOS) in Healthy Subjects (Juniors)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01001949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*